These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 1533192

  • 1. Effect of niceritrol on streptozocin-induced diabetic neuropathy in rats.
    Hotta N, Kakuta H, Fukasawa H, Koh N, Sakakibara F, Komori H, Sakamoto N.
    Diabetes; 1992 May; 41(5):587-91. PubMed ID: 1533192
    [Abstract] [Full Text] [Related]

  • 2. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
    Hotta N, Kakuta H, Fukasawa H, Koh N, Sakakibara F, Nakamura J, Hamada Y, Wakao T, Hara T, Mori K.
    Diabetes Res Clin Pract; 1995 Feb; 27(2):107-17. PubMed ID: 7607048
    [Abstract] [Full Text] [Related]

  • 3. Niceritrol prevents the decrease in red blood cell 2,3-diphosphoglycerate and neuropathy in streptozotocin-induced diabetic rats.
    Hotta N, Nakamura J, Kakuta H, Fukasawa H, Koh N, Sakakibara F, Mori K, Sakamoto N.
    J Diabetes Complications; 1995 Feb; 9(3):133-9. PubMed ID: 7548976
    [Abstract] [Full Text] [Related]

  • 4. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K, Kato N, Matsubara A, Nakano K, Kurono M.
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [Abstract] [Full Text] [Related]

  • 5. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.
    Stevens MJ, Lattimer SA, Kamijo M, Van Huysen C, Sima AA, Greene DA.
    Diabetologia; 1993 Jul; 36(7):608-14. PubMed ID: 8359577
    [Abstract] [Full Text] [Related]

  • 6. A combination of the aldose reductase inhibitor, statil, and the prostaglandin E1 analogue, OP1206.alpha CD, completely improves sciatic motor nerve conduction velocity in streptozocin-induced chronically diabetic rats.
    Yasuda H, Sonobe M, Hisanaga T, Kawabata T, Maeda K, Kikkawa R, Shigeta Y.
    Metabolism; 1992 Jul; 41(7):778-82. PubMed ID: 1320179
    [Abstract] [Full Text] [Related]

  • 7. The significance of nerve sugar levels for the peripheral nerve impairment of spontaneously diabetic GK (Goto-Kakizaki) rats.
    Suzuki K, Yen-Chung H, Toyota T, Goto Y, Hirata Y, Okada K.
    Diabetes Res; 1990 May; 14(1):21-5. PubMed ID: 2134662
    [Abstract] [Full Text] [Related]

  • 8. Effect of a new aldose reductase inhibitor, 8'-chloro-2',3'-dihydrospiro [pyrrolidine-3,6'(5'H)-pyrrolo[1,2,3-de] [1,4]benzoxazine]-2,5,5'- trione (ADN-138), on delayed motor nerve conduction velocity in streptozotocin-diabetic rats.
    Hirata Y, Fujimori S, Okada K.
    Metabolism; 1988 Feb; 37(2):159-63. PubMed ID: 2828821
    [Abstract] [Full Text] [Related]

  • 9. Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve.
    Coppey LJ, Davidson EP, Dunlap JA, Lund DD, Yorek MA.
    Int J Exp Diabetes Res; 2000 Feb; 1(2):131-43. PubMed ID: 11469397
    [Abstract] [Full Text] [Related]

  • 10. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Yorek MA.
    Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057
    [Abstract] [Full Text] [Related]

  • 11. Reversal of deficits in axonal transport and nerve conduction velocity by treatment of streptozotocin-diabetic rats with myo-inositol.
    Tomlinson DR, Mayer JH.
    Exp Neurol; 1985 Aug; 89(2):420-7. PubMed ID: 2410289
    [Abstract] [Full Text] [Related]

  • 12. Reduced motor nerve conduction velocity and Na(+)-K(+)-ATPase activity in rats maintained on L-fucose diet. Reversal by myo-inositol supplementation.
    Yorek MA, Wiese TJ, Davidson EP, Dunlap JA, Stefani MR, Conner CE, Lattimer SA, Kamijo M, Greene DA, Sima AA.
    Diabetes; 1993 Oct; 42(10):1401-6. PubMed ID: 8397126
    [Abstract] [Full Text] [Related]

  • 13. Aldose reductase inhibition with imirestat-effects on impulse conduction and insulin-stimulation of Na+/K(+)-adenosine triphosphatase activity in sciatic nerves of streptozotocin-diabetic rats.
    Carrington AL, Ettlinger CB, Calcutt NA, Tomlinson DR.
    Diabetologia; 1991 Jun; 34(6):397-401. PubMed ID: 1653157
    [Abstract] [Full Text] [Related]

  • 14. Selective effects of myo-inositol administration on sciatic and tibial motor nerve conduction parameters in the streptozocin-diabetic rat.
    Greene DA, Lewis RA, Lattimer SA, Brown MJ.
    Diabetes; 1982 Jul; 31(7):573-8. PubMed ID: 7160537
    [Abstract] [Full Text] [Related]

  • 15. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.
    Ng TF, Lee FK, Song ZT, Calcutt NA, Lee AY, Chung SS, Chung SK.
    Diabetes; 1998 Jun; 47(6):961-6. PubMed ID: 9604875
    [Abstract] [Full Text] [Related]

  • 16. An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy.
    Hara T, Nakamura J, Koh N, Sakakibara F, Hamada Y, Sasaki H, Naruse K, Nakashima E, Takeuchi N, Inukai S.
    J Lab Clin Med; 1995 Dec; 126(6):541-7. PubMed ID: 7490513
    [Abstract] [Full Text] [Related]

  • 17. Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Salvemini D, Yorek MA.
    Br J Pharmacol; 2001 Sep; 134(1):21-9. PubMed ID: 11522593
    [Abstract] [Full Text] [Related]

  • 18. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats.
    Yoshida T, Nishioka H, Yoshioka K, Nakano K, Kondo M, Terashima H.
    Diabetes; 1987 Jan; 36(1):6-13. PubMed ID: 3025043
    [Abstract] [Full Text] [Related]

  • 19. Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats.
    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Yorek MA.
    Diabetes Metab Res Rev; 2002 Jan; 18(1):49-56. PubMed ID: 11921418
    [Abstract] [Full Text] [Related]

  • 20. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR, Moriarty RJ, Mayer JH.
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.